As at November 15, 2024Show prices

SaskWorks Diversified (Class A - Series A) - 27.5059

SaskWorks Diversified (Class A - Series B) - 29.8056

SaskWorks Diversified (Class A - Series F) - 33.0756

SaskWorks Resources (Class R - Series A) - 26.9724

SaskWorks Resources (Class R - Series B) - 35.3832

SaskWorks Resources (Class R - Series F) - 30.0659

News

STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX-V) is pleased to announce the following: (1) it has entered into a share purchase agreement executed on March 21, 2017 to acquire all of the shares of a private Canadian corporation from an arm’s length shareholder for $396,600,000 resulting in StorageVault acquiring a Canadian portfolio of storage assets…

TORONTO, ONTARIO–(Marketwired – Mar 22, 2017) – STORAGEVAULT CANADA INC. (“StorageVault”) (TSX VENTURE:SVI) is pleased to announce the following: (1) it has entered into a share purchase agreement executed on March 21, 2017 to acquire all of the shares of a private Canadian corporation from an arm’s length shareholder for $396,600,000 resulting in…

CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (CMED.TO) today announced the receipt, through its wholly-owned subsidiary Prairie Plant Systems Inc., of the Company’s first two Health Canada issued export permits for medical cannabis oils. In addition, the Company has received initial purchase orders for all three CanniMed® Oils for distribution to both Australia and the Cayman Islands for pharmacy dispensing…

Further to its September 6, 2016, December 23, 2016 and March 10, 2017 news releases, and the waiver of all due diligence conditions for such acquisitions, StorageVault intends to close the purchases of the $7,400,000 Kitchener asset, the $22,000,000 five store Prairie portfolio and the $2,800,000 Kamloops store on or before March 31, 2017. When these acquisitions close, they will add scale to StorageVault’s current operations and will bring the total of number of StorageVault stores across Canada to 56…

Our medical cannabis sales increased dramatically during the quarter, with increasing contribution from oils,” said Brent Zettl, President and CEO of the Company. “We are pleased that our GMP manufacturing process, which includes extensive quality controls, as well as the fact that our process does not involve pesticides, is increasingly being recognized by patients and healthcare professionals. We continue to pursue new market channels, including distribution domestically through pharmacies and internationally through collaborations with foreign healthcare companies…

Back to Top